Elias Zerhouni and Andy Plump discuss the future of multispecific biologics episode artwork

EPISODE · Apr 7, 2025 · 35 MIN

Elias Zerhouni and Andy Plump discuss the future of multispecific biologics

from The Studio at Kendall Square · host BiotechTV

Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They also discuss the differences between pharma and biotech, keys to being an effective R&D leader, and advice for both young and experienced people in their careers.

Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They also discuss the differences between pharma and biotech, keys to being an effective R&D leader, and advice for both young and experienced people in their careers.

NOW PLAYING

Elias Zerhouni and Andy Plump discuss the future of multispecific biologics

0:00 35:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Studio at Kendall Square?

This episode is 35 minutes long.

When was this The Studio at Kendall Square episode published?

This episode was published on April 7, 2025.

What is this episode about?

Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They also discuss the differences between pharma and biotech, keys to being an effective R&D leader, and...

Can I download this The Studio at Kendall Square episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!